Evotec SE EVO
NASDAQ EVO
$1.81 -0.01 (-0.55%)
At close: Sep 9, 2026 · 4:00 PM EDT

Evotec SE (EVO) Net Margin Growth (1y) (2010 - 2025)

Analysis

Evotec SE (EVO) Net Margin Growth (1y) (2010 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Iqvia Holdings 44.06 Bn 42.11 Bn 1.44 Bn -113.00
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn 220.00
3 Charles River Laboratories International 13.77 Bn 13.62 Bn 452.07 Mn -515.00
4 Icon 12.62 Bn 11.69 Bn 479.29 Mn -413.00
5 Fortrea Holdings 1.68 Bn 1.51 Bn 139.20 Mn 5,083.00
6 Evotec SE 661.34 Mn 235.46 Mn - -
7 Ginkgo Bioworks Holdings 442.79 Mn 358.26 Mn 18.44 Mn -7,766.00
8 Champions Oncology 72.49 Mn 72.62 Mn 7.03 Mn 1,003.00
9 MindWalk Holdings 61.66 Mn 53.38 Mn 1.82 Mn 18,691.00
10 VivoSim Labs 1.47 Mn 1.47 Mn - -752,733.00
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 2.46 Mn
Sep 30, 2025 313.00
Jun 30, 2025 -6,643.00
Mar 31, 2025 169.00
Dec 31, 2024 -3.04 Mn
Jun 30, 2024 5,618.00
Dec 31, 2023 -1.08 Mn
Jun 30, 2023 1,025.00
Dec 31, 2022 533,070.00
Sep 30, 2022 -8.41 Mn
Jun 30, 2022 -4.34 Mn
Mar 31, 2022 -8.41 Mn
Dec 31, 2021 -518.00
Sep 30, 2021 8.52 Mn
Dec 31, 2020 -904.00
Jun 30, 2010 8,944.00
Mar 31, 2010 -1,331.00